AAIPharma

Ronald Kershner has been appointed to lead AAIPharma’s North American Biostatistics and Data Management Services groups. Mr. Kershner has more than 25 years of industry experience at several large pharmaceutical, biotechnology and contract research companies. His previous roles include oversight of biostatistics and data management across a variety of therapeutic areas at inVentiv, Inveresk and Omnicare. Mr. Kershner has experience with regulatory submissions and has been involved in more than 20 NDA submissions. He also has experience with the implementation of EDC and eClinical technologies.
    
Mr. Kershner will be responsible for functional and financial oversight of all biostatistics and data management activities for AAI in North America. In this role, he will work closely with clients to insure on-time, on-budget quality deliverables. He will also be involved in new global technology initiatives to provide clients with technological solutions for implementing and managing clinical trials.